Global Blood Ther (GBT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 12-2020 | 12-2019 | 12-2018 | 12-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 684,717 | 494,766 | 302,237 | 275,357 | 198,332 |
| Marketable Securities | N/A | 66,126 | 307,732 | 202,177 | 116,493 |
| Receivables | 28,800 | 17,500 | 2,637 | N/A | N/A |
| Inventories | 58,202 | 40,223 | 1,277 | N/A | N/A |
| Other current assets | 0 | 0 | 4,692 | 1,909 | 5,648 |
| TOTAL | $801,970 | $632,163 | $627,997 | $485,780 | $324,312 |
| Non-Current Assets | |||||
| PPE Net | 34,918 | 37,882 | 27,113 | 14,981 | 16,571 |
| Investments And Advances | 50,057 | 0 | 85,030 | 114,281 | 14,607 |
| Other Non-Current Assets | 52,263 | 53,957 | 55,959 | 2,601 | 1,230 |
| TOTAL | $137,238 | $91,839 | $168,102 | $131,863 | $32,408 |
| Total Assets | $939,208 | $724,002 | $796,099 | $617,643 | $356,720 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 15,097 | 19,078 | 10,621 | 6,046 | 7,177 |
| Accrued Expenses | 67,009 | 55,118 | 58,936 | 26,828 | 18,714 |
| Other current liabilities | 5,892 | 4,836 | 1,896 | 899 | 373 |
| TOTAL | $87,998 | $79,032 | $71,453 | $33,773 | $26,264 |
| Non-Current Liabilities | |||||
| Long Term Debt | 246,352 | 148,815 | 73,559 | N/A | N/A |
| Other Non-Current Liabilities | 408,448 | 79,998 | 72,393 | 11,071 | 11,652 |
| TOTAL | $654,800 | $228,813 | $145,952 | $11,071 | $11,652 |
| Total Liabilities | $742,798 | $307,845 | $217,405 | $44,844 | $37,916 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 64,821 | 62,157 | 60,829 | 56,322 | 47,064 |
| Common Shares | 65 | 62 | 61 | 56 | 46 |
| Retained earnings | -1,289,560 | -986,469 | -738,916 | -472,150 | -297,957 |
| Other shareholders' equity | 100 | 302 | 754 | -48 | -336 |
| TOTAL | $196,410 | $416,157 | $578,694 | $572,799 | $318,804 |
| Total Liabilities And Equity | $939,208 | $724,002 | $796,099 | $617,643 | $356,720 |